Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea · Delayed Price · Currency is KRW 10,450
-550 (-5.00%)
Dec 10, 2025, 3:30 PM KST
Vaxcell-Bio Therapeutics Market Cap
Vaxcell-Bio Therapeutics has a market cap or net worth of 243.04 billion as of December 10, 2025. Its market cap has decreased by -8.01% in one year.
Market Cap
243.04B
Enterprise Value
204.99B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
10,450.00
Market Cap Chart
Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 243.04B, an increase of 51.67%. That is a compound annual growth rate of 8.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 255.83B | 6.68% |
| Dec 30, 2024 | 239.82B | -53.54% |
| Dec 28, 2023 | 516.20B | -0.71% |
| Dec 29, 2022 | 519.87B | -21.31% |
| Dec 30, 2021 | 660.68B | -73.75% |
| Dec 30, 2020 | 2.52T | 1,470.89% |
| Sep 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 716.36T |
| SK hynix | 398.39T |
| LG Energy Solution | 105.65T |
| Samsung Biologics | 75.41T |
| Hyundai Motor Company | 66.51T |
| HD Hyundai Heavy Industries | 51.22T |
| Hanwha Aerospace | 49.39T |
| Doosan Enerbility | 49.38T |